Dr Sheikh Mohammad Fazle Akbar

After the emergence of the pandemic, several repurposed antiviral drugs such as hydroxychloroquine, ivermectin, favipiravir, remdesivir, nitazoxanide, and lopinavir/ritonavir were provided emergency authorisation approval as there was no direct antiviral drug for Covid-19